We are pleased to welcome Volmar Kaipainen to Quantify Research as a Research Associate, based in our Helsinki office.
Volmar holds a bachelorās degree in Econometrics and a masterās degree in Statistics from [ā¦]
We have now completed two engaging days at the World Evidence, Pricing and Access Congress
The conversations have been thoughtful, forward-looking, and grounded in the realities of access across Europe.
AI in evidence generation, implementation of Joint Clinical Assessment JCA, and [ā¦]
A full and energising first day at the World Evidence, Pricing and Access Congress in Amsterdam.
It was a pleasure to reconnect with long-standing connections, meet new ones, and continue conversations across the access community.
We are pleased to be here [ā¦]
š Tomorrow (3 March), BĆ©ranger Lueza, PhD and Abraham Choong will be in Amsterdam for the World Evidence, Pricing and Access Congress.
š You will find us at booth 302, together with our [ā¦]
We have now completed our journey across Denmark, Sweden, Finland and Norway.
Four countries.
Four distinct strengths.
One shared evidence philosophy.
Denmark ā deeply integrated national registries and a strong epidemiological tradition
Swedenā clinically rich quality registries embedded in routine care
Finland ā structured secondary-use frameworks [ā¦]
Norway closes our Nordic RWD series for a reason.
A universal healthcare system, personal identifiers, and decades of national coverage enable true longitudinal follow-up across care settings.
This is not just data availability.
It is [ā¦]
Quantify Research will be attending the World Evidence, Pricing and Access Congress in šAmsterdam, š March 3ā4.
BĆ©ranger Lueza, PhD & Abraham Choong will represent Quantify on site.
You will find us at Booth 302, together [ā¦]
This is the third installment of the RWD sources from the Nordics. This weekās highlight is Finlandās real-world data ecosystem; which is built on something rare: continuity.
š Since the 1960s, nationwide health [ā¦]
Denmark offers one of the worldās most robust environments for real-world evidence generation. Key strengths include:
1ļøā£ Fast access to comprehensive data
The average time to fully process applications at the Danish Health Data [ā¦]
This Wednesday, we gathered in Stockholm for the Quantify Research 2026 Kick-Off.
Colleagues joined from Finland, Norway and Denmark, with our India team participating online.
We reflected on a strong 2025.
Then we set clear priorities for the year ahead.
Our focus remains clear [ā¦]